Provided by Tiger Trade Technology Pte. Ltd.

Incyte

97.14
+0.23000.24%
Post-market: 97.140.00000.00%18:55 EDT
Volume:1.02M
Turnover:98.74M
Market Cap:19.33B
PE:13.72
High:97.60
Open:96.54
Low:96.34
Close:96.91
52wk High:112.29
52wk Low:57.77
Shares:199.01M
Float Shares:163.04M
Volume Ratio:0.48
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.08
EPS(LYR):6.41
ROE:30.82%
ROA:13.89%
PB:3.44
PE(LYR):15.15

Loading ...

Incyte gets orphan designation for treatment of pancreatic cancer

TIPRANKS
·
Yesterday

MacroGenics sells capped Zynyz royalty interest to Sagard for $60 million

Reuters
·
Yesterday

Guggenheim Sticks to Its Buy Rating for Incyte (INCY)

TIPRANKS
·
Yesterday

Incyte Price Target Maintained With a $135.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

H.C. Wainwright Sticks to Its Buy Rating for Incyte (INCY)

TIPRANKS
·
Yesterday

Incyte-partnered Niktimvo wins Australia approval for chronic graft-versus-host disease

Reuters
·
Yesterday

Incyte announces FDA approval of Jakari XR

TIPRANKS
·
May 02

Incyte says FDA approves once-daily Jakafi XR for myelofibrosis, polycythemia vera, GVHD

Reuters
·
May 02

Incyte Announces FDA Approval of Jakafi Xr™ (Ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease

THOMSON REUTERS
·
May 02

Incyte - Jakafi Xr to Be Available for Pharmacy Orders by May 8

THOMSON REUTERS
·
May 02

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 02

A Look At Incyte (INCY) Valuation After Strong Q1 Beat And Reaffirmed Guidance

Simply Wall St.
·
May 01

Incyte Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 30

Vertex director Suketu Upadhyay to step down, won’t seek re-election at annual meeting

Reuters
·
Apr 30

BMO Capital Remains a Sell on Incyte (INCY)

TIPRANKS
·
Apr 29

Incyte (INCY) Gets a Buy from Guggenheim

TIPRANKS
·
Apr 29

Stifel Nicolaus Sticks to Their Buy Rating for Incyte (INCY)

TIPRANKS
·
Apr 29

Wells Fargo Remains a Hold on Incyte (INCY)

TIPRANKS
·
Apr 29

Incyte price target raised to $124 from $121 at BofA

TIPRANKS
·
Apr 29

Incyte (INCY) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Apr 29